Ian Faragher
Overview
Explore the profile of Ian Faragher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
681
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Factors associated with diagnostic and treatment intervals in colorectal cancer: A linked data study
Drosdowsky A, Lamb K, Te Marvelde L, Gibbs P, Dunn C, Faragher I, et al.
Int J Cancer
. 2025 Mar;
PMID: 40079691
This research aimed to assess the length of intervals before diagnosis and treatment for colorectal cancer in Australia using linked datasets, and to determine any factors associated with interval length....
2.
Lotter J, Zhao K, Rouse M, Faragher I, Yeung J
ANZ J Surg
. 2025 Mar;
PMID: 40040504
No abstract available.
3.
Milanzi E, Pelly R, Hayes I, Gibbs P, Faragher I, Reece J
J Surg Oncol
. 2024 Sep;
130(8):1674-1682.
PMID: 39233560
Background And Objectives: High-resolution magnetic resonance imaging (MRI) accuracy for staging preoperative rectal cancer varies across studies. We examined MRI accuracy for T- and N-staging of rectal cancer compared with...
4.
Kei C, Gartrell R, Arafat Y, Degabriele E, Yeung J, Chan S, et al.
Asia Pac J Clin Oncol
. 2024 Feb;
20(3):395-406.
PMID: 38391122
Backgrounds: The coronavirus disease 2019 (COVID-19) has led to major shifts in the management of colorectal cancer (CRC). This study aims to identify the impact and early outcomes of COVID-19...
5.
Gartrell R, Qiao J, Kiss N, Faragher I, Chan S, Baird P, et al.
ANZ J Surg
. 2023 May;
93(9):2166-2171.
PMID: 37209307
Background: There is mounting evidence that suggests sarcopenia can be used to predict survival outcomes in patients with colon cancer. However, the effect on locally advanced rectal cancer (LARC) is...
6.
Wei M, Arafat Y, Lee M, Kosmider S, Loft M, Faragher I, et al.
ANZ J Surg
. 2023 Jan;
93(10):2285-2286.
PMID: 36716258
No abstract available.
7.
Azher H, Beath A, Degabriele E, Faragher I, Chan S, Yeung J
ANZ J Surg
. 2022 Dec;
93(5):1185-1189.
PMID: 36468815
Background: Colorectal cancer poses a major burden. Its incidence increases with age and older patients with comorbidities have a higher likelihood of major complications. This study investigated the impact of...
8.
Wanasinghe D, Arafat Y, Dow C, Myers C, Yeung J, Cho J, et al.
ANZ J Surg
. 2022 Aug;
93(3):760-761.
PMID: 35972728
No abstract available.
9.
Mendis S, Hong W, Ananda S, Faragher I, Jones I, Croxford M, et al.
JNCI Cancer Spectr
. 2022 Jun;
6(1).
PMID: 35699496
Background: Fecal occult blood test (FOBT)-based screening for colorectal cancer (CRC) reduces mortality, with earlier stage at diagnosis a prominent feature. Other characteristics of FOBT screen-detected cancers and any implications...
10.
Gultekin S, Gartrell R, Lu L, Croxford M, Faragher I, Chan S, et al.
ANZ J Surg
. 2022 May;
92(11):2968-2973.
PMID: 35604223
Background: Perineal wound morbidity following abdominoperineal resection (APR) is a significant challenge. Myocutaneous flap-based techniques have been developed to overcome morbidity associated with perineal reconstruction. We reviewed outcomes for patients...